norovirus
associ
intestin
diseas
human
cow
pig
mice
recent
dog
first
canin
noroviru
cnv
identifi
character
itali
subsequ
studi
identifi
cnv
stool
dog
portug
greec
unit
state
investig
preval
cnv
uk
dog
popul
canin
stool
sampl
screen
cnv
qpcr
serum
sampl
screen
anticnv
antibodi
qpcr
rna
extract
canin
stool
sampl
reveal
cnvposit
sampl
base
sampl
collect
diarrhoeic
control
dog
cnv
viruslik
particl
three
differ
cnv
strain
produc
use
recombin
baculovirus
seropreval
screen
undertaken
anticnv
antibodi
identifi
signific
level
canin
serum
sampl
collect
sampl
collect
seroposit
increas
seropreval
time
suggest
cnv
strain
screen
becom
widespread
variat
seropreval
differ
cnv
strain
also
identifi
twothird
dog
seroposit
singl
strain
wherea
remain
third
seroposit
two
three
strain
analys
studi
provid
first
evid
cnv
present
uk
seropreval
identifi
multipl
circul
strain
warrant
studi
increas
awar
recent
discov
canin
viru
norovirus
member
rna
viru
famili
calicivirida
major
caus
human
infecti
gastroenter
worldwid
estim
three
million
peopl
year
uk
suffer
winter
vomit
diseas
caus
human
noroviru
infect
caus
classic
symptom
vomit
diarrhea
malais
outbreak
common
close
semiclos
commun
hospit
care
home
school
cruis
ship
addit
major
burden
norovirus
human
health
norovirus
also
found
associ
intestin
diseas
cow
pig
mice
lion
cat
dog
first
canin
noroviru
cnv
report
singl
dog
enter
itali
subsequ
studi
identifi
cnv
stool
dog
portug
greec
us
date
report
cnv
present
uk
signific
sequenc
variat
found
differ
cnv
strain
identifi
date
norovirus
assign
six
genogroup
base
complet
capsid
sequenc
strain
noroviru
assign
genogroup
share
amino
acid
ident
human
norovirus
group
togeth
genogroup
ii
iv
wherea
cnv
strain
assign
genogroup
iv
vi
human
canin
norovirus
genogroup
iv
share
amino
acid
ident
thu
separ
differ
genotyp
respect
genet
recombin
believ
occur
differ
noroviru
strain
may
explain
signific
heterogen
cnv
strain
identifi
preval
cnv
dog
clinic
sign
gastroenter
across
europ
estim
itali
portug
studi
us
identifi
cnv
preval
canin
diarrhoea
sampl
cnv
also
detect
healthi
dog
associ
infect
clinic
sign
yet
formal
establish
cnv
identifi
dog
also
infect
enter
viral
pathogen
canin
parvoviru
cpv
canin
enter
coronaviru
cecov
thu
elucid
role
cnv
infect
diseas
difficult
serolog
preval
cnv
countri
viru
detect
report
preliminari
serolog
survey
itali
suggest
less
dog
seroposit
genogroup
lion
noroviru
strain
sampl
size
small
human
noroviru
cnv
yet
cultiv
cell
cultur
thu
obtain
suffici
quantiti
viru
serolog
screen
possibl
howev
major
capsid
protein
norovirus
shown
spontan
assembl
viruslik
particl
vlp
recombin
express
appropri
system
product
lion
canin
noroviru
vlp
previous
achiev
proven
effici
way
gener
antigen
serolog
analysi
aim
studi
elucid
import
cnv
uk
dog
popul
evalu
chang
time
prior
inform
cnv
preval
uk
describ
order
address
studi
sought
determin
preval
cnv
rna
canin
fecal
sampl
conjunct
preval
anticnv
antibodi
differ
popul
dog
ethic
approv
requir
studi
clinic
sampl
collect
either
anim
wast
product
surplu
diagnost
requir
deriv
previous
publish
ethic
approv
studi
stool
sampl
collect
dog
admit
four
particip
veterinari
clinic
geograph
distinct
area
across
uk
owner
consent
dog
recruit
studi
pass
stool
whilst
hospit
stool
collect
veterinari
personnel
store
transport
laboratori
whereaft
store
prior
nucleic
acid
extract
stool
sampl
also
collect
healthi
dog
own
veterinari
staff
clinic
well
dog
particip
board
kennel
basic
case
data
record
dog
stool
sampl
collect
includ
age
breed
sex
reason
admiss
recent
histori
enter
diseas
serum
sampl
obtain
two
separ
dog
popul
sampl
collect
rehom
kennel
part
exist
studi
serum
sampl
obtain
diagnost
servic
royal
veterinari
colleg
uk
pet
blood
bank
sera
collect
pet
dog
either
blood
donor
veterinari
patient
blood
collect
biochem
analysi
variou
reason
stool
dilut
wv
phosphatebuff
salin
ph
solid
remov
centrifug
min
viral
nucleic
acid
extract
ml
clarifi
stool
suspens
genelut
tm
mammalian
total
rna
miniprep
kit
sigma
aldrich
accord
manufactur
instruct
intern
extract
control
ad
sampl
nucleic
acid
extract
verifi
remov
pcr
inhibitor
enabl
precis
quantif
viral
nucleic
acid
fix
amount
equin
arter
viru
eav
rna
ad
lysi
buffer
sampl
obtain
eav
concentr
approxim
copi
per
ml
faecal
suspens
qrtpcr
select
screen
method
high
sensit
allow
detect
lower
viral
copi
number
convent
pcr
cnv
sequenc
list
genbank
august
tabl
use
design
cnv
specif
primerprob
primerdesign
ltd
tabl
target
sequenc
highli
conserv
region
rdrp
posit
control
amplicon
use
gener
standard
curv
copi
cnv
amplicon
reliabl
detect
reaction
volum
ml
addit
cnv
sampl
also
screen
two
canin
enter
virus
known
circul
uk
primerprob
use
canin
parvoviru
cpv
canin
enter
coronaviru
cecov
list
tabl
well
primerprob
sequenc
use
detect
intern
extract
control
qrtpcr
protocol
use
improv
eas
effici
sampl
handl
ml
extract
rna
ad
precis
onestep
qrtpcr
mastermix
primerdesign
ltd
pmolml
primer
pmolml
probe
thermal
cycl
protocol
use
qpcr
machin
ab
appli
biosystem
follow
min
inactiv
revers
transcriptas
min
cycl
consist
denatur
anneal
elong
min
three
differ
cnv
strain
maximum
sequenc
differ
select
vlp
product
sequenc
three
gene
obtain
genbank
tabl
restrict
enzym
site
design
noti
strain
bbsi
cnv
strain
bsai
cnv
hk
enabl
later
ligat
baculoviru
transfer
vector
sequenc
synthes
biobas
inc
vector
sequenc
digest
relig
digest
ncoi
noti
neb
correct
sequenc
three
insert
confirm
sequenc
recombin
baculovirus
gener
use
flash
bac
baculoviru
express
system
per
manufactur
instruct
oxford
express
technolog
stock
virus
gener
titrat
cell
store
dark
protein
express
perform
insect
cell
invitrogen
briefli
insect
cell
seed
flask
infect
recombin
baculoviru
multipl
infect
pfucel
infect
allow
proceed
day
prior
protein
harvest
vlp
purif
vlp
purif
perform
essenti
describ
vlp
releas
infect
cell
freezethaw
follow
clarif
remov
cellular
debri
minut
baculoviru
remov
min
vlp
partial
purifi
wv
sucros
cushion
tnc
buffer
mm
tri
hcl
ph
mm
nacl
mm
cacl
contain
proteas
inhibitor
leupeptin
hr
pellet
vlp
resuspend
tnc
purifi
isopyn
centrifug
caesium
chlorid
hr
result
vlp
band
collect
punctur
solut
contain
vlp
dialys
pb
prior
quantif
bca
protein
assay
thermo
scientif
storag
ninetysixwel
polystyren
microtit
plate
nunc
maxisorb
fisher
scientif
coat
overnight
ng
pool
cnv
vlp
consist
ng
strain
hk
carbonatebicarbon
buffer
ph
plate
wash
three
time
tween
phosphat
buffer
salin
pbst
block
skim
milkpbst
h
three
pbst
wash
plate
incub
h
dilut
serum
sampl
duplic
skim
milkpbst
pool
human
sera
sigma
aldrich
dilut
ng
pool
gii
human
noroviru
vlp
use
posit
control
canin
posit
control
identifi
three
wash
pbst
ml
horseradish
peroxidas
hrp
conjug
antidog
igg
antibodi
sigma
aldrich
dilut
milk
pbst
ad
well
incub
h
plate
wash
four
time
pbst
bound
antibodi
detect
ml
tetramethylbenidin
tmb
sigma
aldrich
follow
incub
room
temperatur
min
reaction
stop
n
h
optic
densiti
od
read
nm
spectromax
plate
reader
molecular
devic
elimin
possibl
nonspecif
compon
vlp
prepar
identifi
canin
sera
antigen
distinct
vesiviru
vlp
includ
assay
select
serum
sampl
incub
either
carbonatebicarbon
buffer
coat
well
vesiviru
coat
well
highli
compar
confirm
nonspecif
reactiv
relat
vlp
prepar
occur
background
signal
sampl
henc
determin
measur
serum
sampl
incub
carbonatebicarbon
buffer
alon
background
signal
subtract
vlp
coat
well
gener
correct
valu
threshold
valu
establish
mean
buffer
coat
cell
plu
standard
deviat
serum
sampl
consid
posit
correct
higher
threshold
serum
sampl
show
posit
respons
pool
cnv
vlp
subject
test
individu
cnv
vlp
plate
coat
ng
individu
vlp
carbon
bicarbon
buffer
protocol
repeat
evalu
serolog
cross
reactiv
differ
noroviru
strain
achiev
use
vlp
competit
assay
plate
coat
ngwell
vlp
overnight
cnv
posit
canin
sera
incub
rang
concentr
either
human
noroviru
vlp
individu
cnv
vlp
mgml
h
vesiviru
vlp
incub
canin
sera
neg
control
incub
period
ml
serumvlp
combin
ad
previous
vlp
coat
plate
remaind
elisa
protocol
follow
detail
vlp
heat
approxim
min
presenc
sd
load
buffer
electrophores
sdspolyacrylamid
gel
coomassi
blue
stain
gel
incub
coomassi
blue
h
room
temperatur
prior
destain
western
blot
protein
transfer
sdspolyacrylamid
gel
polyvinyliden
difluorid
membran
membran
block
h
room
temperatur
milk
pbstween
incub
overnight
serum
sampl
dilut
excess
antibodi
wash
three
time
pbst
incub
h
anticanin
igg
secondari
antibodi
conjug
horseradish
peroxidas
sigma
aldrich
wash
away
excess
secondari
antibodi
band
detect
use
enhanc
chemiluminesc
reagent
ge
healthcar
stool
sampl
clinic
data
collect
dog
admit
veterinari
clinic
distribut
across
uk
august
march
mean
age
dog
year
standard
deviat
year
differ
breed
repres
diarrhoea
andor
vomit
last
hr
prior
admiss
report
case
gastrointestin
clinic
sign
proport
case
unlik
attribut
primari
gastroenter
eg
pyometra
foreign
bodi
ingest
thu
overal
found
dog
enrol
studi
suffer
gastroenter
infecti
otherwis
control
sampl
collect
healthi
dog
mean
age
year
standard
deviat
year
board
kennel
belong
veterinari
staff
nucleic
acid
extract
qpcr
success
perform
stool
sampl
determin
constant
c
valu
intern
extract
control
rna
addit
cnv
sampl
systemat
test
presenc
canin
parvoviru
cpv
canin
enter
coronaviru
cecov
tabl
summaris
result
obtain
enter
virus
either
cpv
cecov
detect
high
titr
copiesml
stool
dog
admit
primari
gastroenter
virus
detect
signific
titr
patient
without
gastroenter
healthi
control
dog
sampl
posit
cnv
viral
rna
use
primer
set
describ
tabl
indic
overal
preval
cnv
popul
time
sampl
collect
wilson
binomi
approxim
confid
interv
recombin
baculovirus
express
protein
three
distinct
cnv
isol
gener
use
insect
cell
express
system
produc
cnv
vlp
follow
purif
isopycn
centrifug
cscl
gradient
vlp
readili
visual
sediment
densiti
g
ml
purifi
vlp
quantifi
spectrophotometri
examin
sdspage
stain
coomassi
blue
figur
show
singl
major
protein
appar
molecular
weight
kda
cnv
strain
singl
major
protein
appar
approxim
molecular
weight
kda
strain
hk
differ
molecular
weight
expect
base
sequenc
length
vlp
unrel
caliciviru
vesiviru
includ
control
total
canin
sera
test
elisa
antibodi
cnv
cohort
cohort
part
initi
screen
cnv
vlp
three
strain
hk
combin
dilut
canin
sera
examin
reactiv
cnv
overal
found
seroposit
cnv
cohort
dog
seroposit
cohort
dog
seroposit
increas
seropreval
two
cohort
statist
signific
ztest
determin
serolog
titr
seroposit
dog
ten
seroposit
sampl
randomli
select
cohort
cohort
sera
serial
dilut
twofold
start
dilut
ad
pool
cnv
vlp
ng
strain
per
well
coat
onto
plate
rang
titr
identifi
figur
vari
dog
preval
titr
preliminari
screen
serum
sampl
identifi
posit
initi
elisa
screen
pool
cnv
vlp
test
individu
cnv
vlp
result
show
signific
variat
seropreval
differ
strain
figur
cnv
strain
hk
predomin
cohort
dog
wherea
strain
show
lowest
seropreval
group
data
also
indic
proport
dog
seroconvert
one
cnv
strain
use
studi
cohort
dog
seroposit
strain
percentag
increas
cohort
determin
strain
specif
anticnv
reactiv
identifi
posit
sampl
seri
block
assay
perform
two
select
sampl
firstli
shown
preincub
serum
sampl
posit
pool
cnv
vlp
human
noroviru
vlp
genogroup
ii
diminish
signal
cnv
figur
demonstr
appar
reactiv
cnv
consequ
crossreact
human
noroviru
strain
investig
antigen
relationship
differ
cnv
strain
block
assay
next
perform
use
individu
cnv
strain
cnv
seroposit
sampl
preincub
cnv
strain
vlp
subsequ
detect
elisa
strain
vlp
coat
plate
reduc
preincub
vlp
differ
cnv
strain
diminish
signal
similar
result
shown
serum
preincub
cnv
strain
hk
vlp
detect
hk
vlp
elisa
reduc
figur
serum
contain
anticnv
strain
antibodi
avail
suffici
quantiti
block
assay
though
result
preincub
vlp
suffici
indic
cross
reactiv
strain
hk
occur
data
overal
demonstr
anticnv
antibodi
three
strain
use
studi
strain
specif
suggest
cnv
exist
distinct
serotyp
western
blot
analysi
cnv
vlp
use
repres
posit
canin
serum
sampl
use
addit
method
confirm
specif
anticnv
antibodi
figur
elisa
select
serum
posit
cnv
strain
hk
proven
western
blot
age
time
blood
sampl
known
dog
cohort
mean
age
dog
seroposit
cnv
year
sd
wherea
mean
age
seroneg
dog
year
sd
differ
age
distribut
two
group
statist
signific
p
mannwhitney
test
divis
dog
agegroup
calcul
proport
group
seroposit
cnv
show
seropreval
increas
less
year
age
almost
year
age
group
figur
studi
describ
first
evid
cnv
present
uk
dog
popul
whilst
previou
report
confirm
exist
cnv
throughout
europ
us
confirm
presenc
cnvspecif
antibodi
dog
uk
strongli
suggest
cnv
circul
seropreval
cnv
canin
serum
sampl
collect
compar
seropreval
anoth
enter
viru
cecov
report
vari
popul
uk
dog
cnv
seropreval
unexpectedli
high
given
cnv
rna
detect
canin
stool
sampl
analys
studi
high
seropreval
suggest
mani
dog
expos
viru
inabl
detect
activ
secret
viral
rna
attribut
two
possibl
factor
firstli
like
major
human
noroviru
infect
man
cnv
infect
acut
viru
shed
short
period
time
acut
gastroenter
caus
human
noroviru
man
result
peak
viral
shed
day
infect
week
infect
case
still
posit
viral
rna
preliminari
epidemiolog
data
studi
involv
kennel
outbreak
cnv
seven
dog
found
viru
detect
one
week
onset
clinic
sign
worth
note
although
human
noroviru
respons
million
infect
worldwid
year
viru
identifi
approxim
diarrhoeic
sampl
submit
analysi
second
explan
low
preval
antigen
detect
could
due
genet
heterogen
cnv
signific
sequenc
variat
shown
cnv
strain
character
far
evid
recombin
canin
noroviru
strain
norovirus
differ
genogroup
design
primerprob
use
studi
base
highli
conserv
region
cnv
genom
small
sequenc
differ
affect
abil
viral
sequenc
amplifi
although
strain
circul
uk
antigen
similar
previous
identifi
strain
minor
sequenc
differ
could
reduc
chanc
detect
pcr
screen
address
primer
set
design
broadli
reactiv
wide
rang
norovirus
sapovirus
use
reanalyz
sampl
addit
must
note
primerprob
use
qpcr
survey
cnv
rna
design
prior
public
hk
sequenc
hk
sequenc
differ
primerprob
use
qpcr
survey
would
detect
strain
hk
light
result
serosurvey
issu
address
retrospect
first
viral
rna
survey
new
primer
set
design
detect
conserv
region
hk
protein
sybrbas
qpcr
assay
use
screen
stool
sampl
presenc
noroviru
strain
use
primer
pair
also
specif
cnv
strain
hk
use
newli
design
primer
pair
posit
sampl
identifi
use
either
primer
pair
data
shown
seropreval
cnv
strain
survey
studi
shown
significantli
increas
past
decad
popul
studi
cohort
dog
seroposit
wherea
cohort
proport
almost
doubl
data
provid
first
proof
cnv
present
dog
least
year
prior
initi
discoveri
also
impli
number
dog
expos
strain
cnv
significantli
increas
period
conclus
come
certain
caveat
howev
studi
popul
dog
use
directli
compar
sampl
collect
dog
rehom
kennel
week
wherea
dog
privat
own
pet
seropreval
overal
viral
preval
mani
virus
known
higher
facil
dog
kept
close
contact
suggest
appar
increas
seropreval
cnv
strain
studi
real
typic
own
pet
expos
less
frequent
virus
dog
kennel
would
valuabl
assess
current
cnv
seropreval
kennel
dog
predict
greater
vlp
three
differ
cnv
strain
pool
togeth
establish
overal
seropreval
viru
cnv
strain
includ
identifi
itali
portug
hong
kong
hk
follow
initi
serosurvey
pool
vlp
posit
sampl
enter
elisa
vlp
individu
strain
separ
data
would
indic
reactiv
three
strain
uk
dog
popul
block
assay
demonstr
signific
crossreact
three
cnv
strain
sampl
test
prove
antibodi
gener
respons
infect
like
strain
specif
human
immun
respons
human
noroviru
short
durat
week
homotyp
ie
immun
acquir
genogroup
particular
genotyp
provid
effect
protect
anoth
genogroup
genotyp
studi
therefor
reveal
least
three
antigen
distinct
cnv
strain
circul
uk
dog
popul
similar
coexist
human
noroviru
strain
human
popul
genogroup
genogroup
ii
strain
circul
despit
coexist
multipl
human
noroviru
strain
genogroup
ii
gii
norovirus
preval
genogroup
worldwid
human
outbreak
attribut
strain
data
also
identifi
variat
preval
differ
strain
highest
seropreval
cohort
demonstr
cnv
strain
hk
see
tabl
strain
classifi
gvi
noroviru
along
portugues
strain
howev
strain
hk
highest
sequenc
ident
intergenotyp
gii
recombin
human
noroviru
strain
suggest
strain
hk
may
classifi
novel
genogroup
asid
phylogenet
inform
possibl
determin
higher
seropreval
strain
hk
studi
due
viral
fit
advantag
molecular
character
requir
age
seroconvers
cnv
show
exposur
viru
typic
occur
first
year
life
seropreval
increas
significantli
older
dog
compar
seroconvers
rate
human
noroviru
man
seropreval
children
less
year
old
rapidli
increas
older
children
specul
cnv
isol
stool
sampl
use
qpcr
like
younger
cohort
dog
conclud
report
demonstr
cnv
present
within
uk
dog
popul
also
shown
multipl
strain
cnv
cocircul
evid
exposur
cnv
prior
first
discoveri
also
present
rise
seropreval
time
suggest
pathogen
becom
increasingli
common
uk
